Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Fentanyl/methadone/oxycodone

Opioid use disorder, withdrawal symptoms and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Salapenka I, et al. Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder. Primary Care Companion for CNS Disorders 24: no pagination, No. 6, Jan 2022. Available from: URL: https://www.psychiatrist.com/pcc/ Salapenka I, et al. Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder. Primary Care Companion for CNS Disorders 24: no pagination, No. 6, Jan 2022. Available from: URL: https://​www.​psychiatrist.​com/​pcc/​
Metadaten
Titel
Fentanyl/methadone/oxycodone
Opioid use disorder, withdrawal symptoms and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41447-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Cotrimoxazole

Case report

Multiple drugs